ANTIEMETIC THERAPY FOR CHEMOTHERAPY-INDUCED VOMITING - METOCLOPRAMIDE, BENZTROPINE, DEXAMETHASONE, AND LORAZEPAM REGIMEN COMPARED WITH CHLORPROMAZINE ALONE

被引:31
作者
MARSHALL, G
KERR, S
VOWELS, M
OGORMANHUGHES, D
WHITE, L
机构
[1] PRINCE WALES HOSP, DEPT PAEDIAT HAEMATOL & ONCOL, RANDWICK, NSW 2031, AUSTRALIA
[2] UNIV NEW S WALES, SCH PAEDIAT, SYDNEY, NSW, AUSTRALIA
关键词
D O I
10.1016/S0022-3476(89)80354-3
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:156 / 160
页数:5
相关论文
共 22 条
[1]   METOCLOPRAMIDE - DOSE-RELATED TOXICITY AND PRELIMINARY ANTIEMETIC STUDIES IN CHILDREN RECEIVING CANCER-CHEMOTHERAPY [J].
ALLEN, JC ;
GRALLA, R ;
REILLY, L ;
KELLICK, M ;
YOUNG, C .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (08) :1136-1141
[2]   ADVANCES IN ANTI-EMETIC THERAPY [J].
BAKOWSKI, MT .
CANCER TREATMENT REVIEWS, 1984, 11 (03) :237-256
[3]   LORAZEPAM - A RANDOMIZED, DOUBLE-BLIND, CROSSOVER STUDY OF A NEW ANTIEMETIC IN PATIENTS RECEIVING CYTO-TOXIC CHEMOTHERAPY AND PROCHLORPERAZINE [J].
BISHOP, JF ;
OLVER, IN ;
WOLF, MM ;
MATTHEWS, JP ;
LONG, M ;
BINGHAM, J ;
HILLCOAT, BL ;
COOPER, IA .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (06) :691-695
[4]  
BORISON HL, 1953, PHARMACOL REV, V5, P193
[5]   ON THE RECEIVING END PATIENT PERCEPTION OF THE SIDE-EFFECTS OF CANCER-CHEMOTHERAPY [J].
COATES, A ;
ABRAHAM, S ;
KAYE, SB ;
SOWERBUTTS, T ;
FREWIN, C ;
FOX, RM ;
TATTERSALL, MHN .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (02) :203-208
[6]  
DOLGIN MJ, 1985, PEDIATRICS, V75, P547
[7]  
ENCK RE, 1977, LANCET, V2, P972
[8]   COMBINATION ANTIEMETIC THERAPY IN THE CONTROL OF CHEMOTHERAPY-INDUCED EMESIS [J].
FORTNER, CL ;
FINLEY, RS ;
GROVE, WR .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (01) :21-24
[9]   ANTIEMETICS IN CHILDREN RECEIVING CANCER-CHEMOTHERAPY - A DOUBLE-BLIND PROSPECTIVE RANDOMIZED STUDY COMPARING METOCLOPRAMIDE WITH CHLORPROMAZINE [J].
GRAHAMPOLE, J ;
WEARE, J ;
ENGEL, S ;
GARDNER, R ;
MEHTA, P ;
GROSS, S .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (07) :1110-1113
[10]  
GRAHAMPOLE J, 1984, P AN M AM SOC CLIN, V3, P104